HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF TADALAFIL AND SILDENAFIL IN BULK AND TABLET DOSAGE FORM

  • Mayur S. Jain
  • Dr. Shailesh K. Koradia
Keywords: Tadalafil and Sildenafil, HPLC, Validation

Abstract

The current work aims to establish a validated RP-HPLC method for estimating the combined dosage of sildenafil and tadalafil. Using ZORBAX C18 (250 x 4.6, 5 µ) as a stationary phase and mobile phase, the medicines were separated appropriately: Acetate Buffer: Methanol 10:90 with a mobile phase flow rate of 0.7 mL/min., at 280 mm detection was carried out. Sildenafil's Rt was 4.611 minutes, while Tadalafil's was 3.744 minutes. Tadalafil and sildenafil had respective percentage drug contents of 98.63% when the commercial formulation was examined using the established approach. In the 50–150 PPM range for Tadalafil and 50–150 PPM range for Sildenafil, the approach was determined to be linear.. The results showed that the quantitation limit for sildenafil was 1.65 PPM and the detection limit for tadalafil was 5 PPM. For both medications, the accuracy and precision scores were  found to be close to 100% w/w. Additionally, the approach was proven to be specific and robust. Tadalafil and sildenafil in combination dosage form were found to be linear, specific, sensitive, precise, accurate, and robust when analyzed using the proposed RP-HPLC technique.

 

Author Biographies

Mayur S. Jain

Department Of Pharmaceutical Chemistry And Quality Assurance Krishna School Of Pharmacy And Research,Drs Kiran And Pallavi Patel Global University Vadodara ,India 

Dr. Shailesh K. Koradia

Department Of Pharmaceutical Chemistry And Quality Assurance Krishna School Of Pharmacy And Research,Drs Kiran And Pallavi Patel Global University Vadodara ,India 

References

1. Webb, D.J.; Freestone, S.; Allen, M.J.; Muirhead, G.J. (March 4, 1999). "Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist". Am. J. Cardiol. 83 (5A): 21C–28C. doi:10.1016/S0002-9149(99)00044-2. PMID 10078539
2. The Journal of Urology, Volume 177, Issue 3, Pages 1071-1077 K. McVary, W. Monnig, J. Camps Jr., J. Young, L. Tseng, G. van den Ende.
3. J. D. Corbin and S. H. Sharron. "Molecular Biology and Pharmacology of PDE-5-Inhibitor Therapy for Erectile Dysfunction". J. Androl. 24: S38-S41.
4. J. D. Corbin and S. H. Sharron. "Molecular Biology and Pharmacology of PDE-5-Inhibitor Therapy for Erectile Dysfunction". J. Androl. 24: S38-S41.
5. C.Ho and G.L.Chen, stability indicating HPLC Assay methods for Drug in Pharmaceutical dosage forms: Part-I, J Food Drug Anal.4(1996)271-292.
6. Samuel R.Gartz. PhD. E.D. Drugs and analogs; Characterization of phosphodiesterase- 5 Inhibitors in suspect couterfeit and herbal products. USP Annual Scientific Meeting. 2007.
7. World Health Organization (WHO). National Policy on Traditional Medicine and Regulation of Herbal Medicines. Geneva: Report of WHO global survey. 2005.
8. Kannappan N, Deepth Y, Divya Y, Shashihanth MR. Method Development and Validation of Stability-indicating Methods for assay of Tadalafil and Sildenafil Citrate by HPLC. Int J ChemTech Res. 2010; 2(1): 329-333.
9. Amr MB, Abd El-Aziz B AE, Nesrine TL. Stability indicating methods for the determination of sildenafil in the presence of its degradation product. Int J Compr Pharma. 2011; 2 (7).
10. International Conference on Harmonization (ICH). Harmonized Tripartite Guideline Validation Of Analytical Procedures :Text and methodology Q2(R1) Current Step 4 version Parent Guideline October 1994 page11,2.
How to Cite
Mayur S. Jain, & Dr. Shailesh K. Koradia. (1). HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF TADALAFIL AND SILDENAFIL IN BULK AND TABLET DOSAGE FORM. Revista Electronica De Veterinaria, 25(1S), 1858-1874. https://doi.org/10.69980/redvet.v25i1S.1719